PTC Therapeutics
PTCT
PTCT
203 hedge funds and large institutions have $3.3B invested in PTC Therapeutics in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 83 increasing their positions, 65 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 201 → 203 (+2)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
13% less capital invested
Capital invested by funds: $3.81B → $3.3B (-$502M)
Holders
203
Holding in Top 10
4
Calls
$18.4M
Puts
$4.76M
Top Buyers
| 1 | +$39.1M | |
| 2 | +$32.8M | |
| 3 | +$29.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$19.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17.6M |
Top Sellers
| 1 | -$57.2M | |
| 2 | -$20.4M | |
| 3 | -$12.6M | |
| 4 |
Holocene Advisors
New York
|
-$11.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$10.3M |